Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04546737
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-08
First Post:
2020-09-10
Brief Title:
Study of Morphological Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
Sponsor:
Centre Hospitalier Universitaire Amiens
Organization:
Centre Hospitalier Universitaire Amiens
Study Overview
Official Title:
Study of Morphological Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NSpectroCovid
Brief Summary:
Viral pandemics such as HIV and SARS-Cov-V1 have shown that they can lead to acute and or delayed neurological complications At the actual context of the pandemic Coronavirus disease 2019 COVID-19 neurological manifestations seem to be confirmed since in 85 of COVID-19 patients present neurological symptoms including anosmia ageusia periorbital pain dizziness fatigue even moderate headache moderate memory andor behavioral disorders
However these neurological manifestations are not well studied and their radiological features are not well described It is therefore important to assess these potential neurological complications in COVID-19 patients To the investigator knowledge there is no previous study in the literature describing spectral brain changes in COVID patients Thus the goal of this work is to describe the radiological semiology using MRI and particularly Magnetic Resonance Spectroscopic MRS biomarkers in the evaluation of acute and or delayed brain damage in COVID patients presenting a neurological manifestations that are initially related to the cranial nerves damage
However these neurological manifestations are not well studied and their radiological features are not well described It is therefore important to assess these potential neurological complications in COVID-19 patients To the investigator knowledge there is no previous study in the literature describing spectral brain changes in COVID patients Thus the goal of this work is to describe the radiological semiology using MRI and particularly Magnetic Resonance Spectroscopic MRS biomarkers in the evaluation of acute and or delayed brain damage in COVID patients presenting a neurological manifestations that are initially related to the cranial nerves damage
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None